However, these mice were not fully protected from metastatic disease, unlike the mice inoculated with AKT2-depleted cells, suggesting AKT2 activity may be most impactful at the stage of extravasation, and its effect on tumor growth at the metastatic site was moderate. The gene discussed is AKT2; the disease is neoplasm.